GetTopicDetailResponse(id=cc921e62822, topicName=Toll樣受體4, introduction=Toll樣受體4, content=null, image=null, comments=0, allHits=1058, url=https://h5.medsci.cn/topic?id=17628, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=50565, tagList=[TagDto(tagId=50565, tagName=Toll樣受體4)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2216491, encodeId=f9bd221649109, content=<a href='/topic/show?id=9c5a3243ef4' target=_blank style='color:#2F92EE;'>#刺突蛋白#</a> <a href='/topic/show?id=cc921e62822' target=_blank style='color:#2F92EE;'>#Toll樣受體4#</a> <a href='/topic/show?id=466e159032f' target=_blank style='color:#2F92EE;'>#SARS-COV-2#</a>, objectTitle=新冠刺突蛋白的免疫表位及通用疫苗的開發(fā)考量, objectType=article, longId=835082, objectId=399b835082d5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240704/1720089445924_8538692.jpg, objectUrl=/article/show_article.do?id=399b835082d5, replyNumber=0, likeNumber=72, createdTime=2024-07-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=399b835082d5, moduleTitle=新冠刺突蛋白的免疫表位及通用疫苗的開發(fā)考量, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=399b835082d5)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
